Table 4:

Summary of factors related to facial abnormalities discussed in the text

FactorSome Observed Abnormalities
RAExcess leads to fusion of 1st and 2nd branchial arches and acoustic-facial ganglia, small jaws, cleft palate, deformed pinna (Treacher-Collins syndrome); RA controls Shh and Fgf8 levels
FgfControls outgrowth of facial primordia and migration of neural (Fgf) crest cells to facial processes; a decrease in FBGFR1 leads to midline clefting and Kallmann syndrome, small face and skull, achondroplasia, Crouzon syndrome, Apert syndrome
TGFTGFβ required for fusion of lateral palatal processes; a decrease leads to defects in maxillary and mandibular development
BMPA decrease leads to short frontal and nasal bones and small pterygoid processes, short stature, ear defects, odontogenic patterning defects, slower neural tube closure, small branchial arches, loss of incisor teeth
Shh proteinA decrease leads to holoprosencephaly, hypotelorism; an increase leads to a wide forehead, frontonasal dysplasia, Gorlin syndrome, Grieg cephalopolysyndactyly, Smith-Lemli-Opitz syndrome
WntsA decrease leads to loss of teeth, truncation of jaw, mesencephalic nucleus, and trigeminal nerve
ET-1A decrease leads to aplasia of 1st and 2nd arches, defects in maxilla and cleft palate, malformations of middle and external ear; 22q11.2 deletion syndrome (CATCH22 syndrome)
Jagged 1 and 2A decrease leads to Alagille syndrome, failure of palatal shelves to elevate, and fusion of shelves with tongue
Platelet-derived growth factorsA decrease leads to loss of some facial bones
Homeobox-containing genesA decrease leads to primitive facial morphology, cleft palate, short maxilla and mandible, loss of maxillary molar teeth, ankyloglossia
  • Note:—RA indicates retinoic acid; FGFR, fibroblast growth factor receptor; PDGFR, platelet-derived growth factor receptor.